Skip to main content
Caplight Logo









Mesh Bio

Mesh Bio

Private
SingaporeHealthcare & Life Scienceshttps://www.meshbio.com/

Last Round

Series A

Jan 30, 2024

Total Funding Raised

$5.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mesh Bio is a health technology company that provides a multidimensional health intelligence platform designed to transform chronic disease management through predictive analytics.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Data as a Service

AI Layer

Application

Keywords

chronic disease managementpredictive analyticsdigital twinclinical decision supportmedical AISoftware as a Medical DeviceSaMDhealth intelligence platformpatient risk stratificationdigital healthhealthcare analyticsmetabolic digital twinprecision medicineclinical workflow automationB2B healthcare SaaSmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mesh Bio Comparables

Compare Mesh Bio with similar companies based on industry and business-model similarity.

Mesh Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prealize Health
71%
ClosedLoop
63%
Biofourmis
63%

Mesh Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 30, 2024
SeedMar 10, 2021

Key People

Founding team and executive leadership

Arsen Batagov

Co-Founder And CTO

Founding Team

Andrew Wu

Co-Founder And CEO

Founding Team

Adrian CHUA

Chief Operating Officer

Executive Team

Mesh Bio Investors

Notable investors and investment history

Mesh Bio investors
InvestorRounds
SEEDS CapitalSeries A, Seed
East VenturesSeries A
TAEL PartnersSeed
Elev8.vcSeries A, Seed
Citrine Capital Sdn BhdSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 34% MoM, reaching 12.1K.

  • Jun 17, 2026

    Monthly visitors increased 179% MoM, reaching 9K.

Mesh Bio Filings

Explore SEC and related filing metadata, where available.

Mesh Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mesh Bio's valuation, stock price, and market status.

Is Mesh Bio a public or private company?

Mesh Bio is a private company.

What is the current stock price of Mesh Bio?

Mesh Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Mesh Bio worth (valuation)?

Valuation information for Mesh Bio is not publicly available.

Can I buy Mesh Bio stock?

Mesh Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mesh Bio's last funding round?

Mesh Bio's most recent funding round was Series A on January 30, 2024.

Who are the main investors in Mesh Bio?

Key investors in Mesh Bio include SEEDS Capital, East Ventures, Elev8.vc.

Will Mesh Bio IPO soon?

No public IPO plans have been announced for Mesh Bio.

How can I track Mesh Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mesh Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range21
Year Founded2018
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?